icon-folder.gif   Conference Reports for NATAP  
 
  66th Annual Meeting of the
American Association for the
Study of Liver Diseases
Boston, MA Nov 13-17 2015
Back grey_arrow_rt.gif
 
 
 
Efficacy, Safety and Pharmacokinetics of Grazoprevir (MK-5172) and Elbasvir (MK-8742) in Hepatitis C Genotype 1 Infected Non-cirrhotic Japanese Patients (Phase 2 Portion in Phase 2/3 Combined Study)
 
 
  Reported by Jules Levin
AASLD 2015 Nov 13-17 San Francisco
 
Norifumi Kawada1; Fumitaka Suzuki2; Yoshiyasu Karino3; Kazuaki Chayama4; Yoshito Itoh5; Takeshi Okanoue6; Makoto Nakamuta7; Naoyoshi Yatsuzuka8; Go Fujimoto8; Lisa Chiacchierini Lupinacci9; Michael N. Robertson9; Luzelena Caro9; Daniel Tatosian9; Anita Y.M. Howe9; Hiromitsu Kumada2
1Department of Hepatology, Osaka City University Medical School, Osaka, Japan; 2Department of Hepatology, Toranomon Hospital, Tokyo, Japan; 3 Department of Gastroenterology, Sapporo Kosei General Hospital, Hokkaido, Japan; 4Department of Gastroenterology and Metabolism, Hiroshima University, Hiroshima, Japan; 5Department of Molecular Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine, Kyoto, Japan;
6 Department of Gastroenterology and Hepatology, Saiseikai Suita Hospital, Osaka, Japan; 7Department of Gastroenterology, Kyushu Medical Center, National Hospital Organization, Fukuoka, Japan; 8MSD K.K., Tokyo, Japan; 9Merck & Co., Inc., Kenilworth, NJ, USA

AASLD1.gif

AASLD2.gif

AASLD3.gif

AASLD4.gif

AASLD5.gif

AASLD6.gif

AASLD7.gif

AASLD8.gif

AASLD9.gif